MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617077429 A) filed by Actio Biosciences, Inc. on June 23, 2026, for Heterocyclic Compounds Useful As Kcnt1 Inhibitors.
Inventors include Stock, Nicholas Simon; Govek, Steven; and Katana, Ashley.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: The present disclosure provides compounds and pharmaceutical compositions thereof, and methods of using the same.
Disclaimer: Curated by HT Syndication.
